Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000555

Drug Information
NameLu AA21004
CompanyTakeda
IndicationMood and anxiety disorders
[ICD9: 296, 300   ICD10: F30-F39, F40-F42]
Phase III    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C18H22N2S.BrH/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-1
1-9-19-10-12-20;/h3-8,13,19H,9-12H2,1-2H3;1H
InChIKeyVNGRUFUIHGGOOM-UHFFFAOYSA-N
Canonical SMILESCC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br    
PubChem Compound IDCID 56843850.
ClinicalTrials.govNCT00735709;
Target5-hydroxytryptamine receptorModulator[2]
Ref 1Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology. 2008 Aug;33(9):2080-92. Epub 2008 Jan 2. To Reference
Ref 2Takeda. Product Development Pipeline. July 31 2009. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543